Vaginal misoprostol for abortion at 10-13 weeks' gestation

European Journal of Contraception and Reproductive Health Care

Volumn 4, Issue 1, 1999, Pages 35-40

  Carbonell Esteve, J Ll ^b   Varela, L ^a   Velazco, A ^a   Tanda, R ^a   Sanchez C ^a  

^a Hosp Docente Gineco Obstet E H   (Cuba)

^b Mediterranea Medica Clinic   (Spain)

Author keywords

Abortion; Misoprostol; Pregnancy termination

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN DERIVATIVE;

ABORTION; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREGNANCY TERMINATION; PRIORITY JOURNAL; VAGINA BLEEDING;

EID: 0037959907     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189909043478     Document Type: Article

References (15)

1. 1. Norman JE, Thong KJ, Baird DT. Uterine contractility and inducing of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991; 338: 1233-6
2. 1 on bronchodilation in bronchial spasm. Polski Tygodnyk Lekarski 1992; 47: 733-4
3. 3. Carbonell JLL, Varela L, Velazco A, Fernández C. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55: 165-8 4.
4. Carbonell JLL, Varela L, Velazco A, Fernández C, Sánchez C. The use of misoprostol for abortion ≤ 9 weeks' gestation. Eur J Contracept Reprod Health Care 1997; 2: 181-5
5. 5. Carbonell JLL, Varela L, Velazco A, Cabezas E, Tanda R, Sánchez C. Vaginal misoprostol for late first trimester abortion. Contraception 1998; 57: 329-33
6. 6. Bugalho A, Bique C, Pereira C, Granja AC, Bergstrom S. Uterine evacuation by vaginal misoprostol after second trimester pregnancy interruption. Acta Obstet Gynecol Scand 1996; 75: 270-3
7. 7. Carbonell JLL, Varela L, Velazco A, Tanda R, Sánchez C. Vaginal misoprostol for early second trimester abortion. Eur J Contracept Reprod Health Care 1999; 3: 93-8
8. 2 or endocervical misoprostol. A comparative study. Acta Obstet Gynecol Scand 1998; 77: 429-32
9. 9. Chung T, Leung P, Cheung LP, Haines C, Chang AM. A medical approach to management of spontaneous abortion using misoprostol. Acta Obstet Gynecol Scand 1997; 76: 248-51
10. 10. Ficicioglu C, Tasdemir M, Tasdemir S. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks gestation. Acta Obstet Gynecol Scand 1996; 75: 54-6
11. 11. Goldstein S. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991; 165: 497-50
12. 12. Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996; 54: 323-7
13. 13. El Reafey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995; 10: 475-8
14. 14. Webster D, Penney GC, Templeton A. A comparison of 600 mg and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996; 103: 706-9
15. 15. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9-13 weeks amenorrhoea with mifepristone and misoprostol. Lancet 1998; 352: 542-3